Why Avantor J.T.Baker BAKERBOND ABx Pro columns aim for cleaner bioprocessing

Reviewed: ad hoc news Lifestyle & Consumer desk. Edited and checked on 2026-06-19, 06:36. Details in the imprint.

With the J.T.Baker BAKERBOND ABx Pro columns, Avantor puts a compact white cylinder on the bench that promises quieter downstream shifts - fewer do-overs, more predictable polishing runs, and less hand-wringing over antibody purity in the final step.

What BAKERBOND ABx Pro is built for

The J.T.Baker BAKERBOND ABx Pro columns are anion exchange chromatography columns designed mainly for polishing monoclonal antibodies and other therapeutic proteins in downstream bioprocessing. The resin is based on a strong anion exchanger and targets acidic impurities and aggregates in late purification steps.

Avantor positions ABx Pro as a higher capacity, higher resolution upgrade to its legacy ABx resin, keeping the same backbone chemistry while optimizing ligand density and pore structure for modern high-titer feeds. In practice that means shorter runs or fewer cycles to hit the same purity specifications on a packed skid.

How the column feels in daily lab use

On the bench the prepacked ABx Pro column looks unspectacular - clear body, tidy white frits, standard Luer-style connections. The difference shows when the skid ramps up: pressure stays stable, gradient changes feel smooth, and the UV trace looks cleaner than with older resins at comparable loadings.

Technicians will notice that ABx Pro tolerates reasonably fast linear velocities without spiking back pressure, which helps fit more cycles into a shift. Cleaning-in-place using typical caustic solutions is supported by Avantor's specifications, allowing multi-batch reuse in a GMP environment.

Performance and selectivity in bioprocessing

According to Avantor's application data, ABx Pro offers increased dynamic binding capacity compared with the original ABx, especially at shorter residence times relevant for industrial polishing steps. That gives process engineers room to compress columns, reduce bed heights, or push higher feed concentrations without losing resolution.

The resin's selectivity is tuned to separate monomeric antibodies from acidic variants and larger aggregates, a typical bottleneck in polishing mAb processes. Combined with carefully shaped salt or pH gradients, this lets developers sharpen critical quality attributes like charge variant distribution and high-molecular-weight species content.

Integration into existing platforms

ABx Pro is designed to drop into existing chromatography skids that already run J.T.Baker columns, minimizing requalification effort. Avantor offers the resin in prepacked columns spanning small development formats to larger pilot scales, so platform teams can scale conditions without swapping chemistry.

The company also promotes ABx Pro as part of a broader bioprocessing workflow that includes buffers, single-use fluid handling, and analytical support. That ecosystem approach is meant to reduce friction when a drug program moves from R&D labs into clinical and commercial manufacturing, where every change control costs time and nerves.

Where its limits and trade-offs sit

No resin solves every downstream challenge, and ABx Pro is no exception. Strong anion exchangers can struggle when feed variability is extreme, or when the impurity profile shifts significantly during a product's lifecycle. In those cases platforms may still require complementary chromatography steps or membrane polishing.

Cost can also be a quiet deciding factor. High-performance resins like ABx Pro typically carry a premium over legacy materials, which process teams must offset via higher capacity, fewer cycles, or reduced column sizes. For smaller biotech players, that cost-benefit calculation is more sensitive than for big pharma lines running 24/7.

Availability and who Avantor targets

BAKERBOND ABx Pro is marketed globally through Avantor's life sciences distribution network, with strong focus on North America, Europe, and major Asian biopharma hubs. The product is aimed squarely at process development labs, pilot plants, and commercial biologics facilities working on antibodies and recombinant proteins.

Because prepacked columns are available in multiple dimensions, the same resin can accompany a molecule from early screening in a compact lab rack through to validation on production-scale skids. That continuity is attractive for teams who dread reformulating steps late in development, with regulators already watching closely.

Company context and stock reference

J.T.Baker is one of Avantor Inc's core brands for bioprocessing materials, complementing the group's broader portfolio that ranges from lab chemicals to single-use assemblies for biologics manufacturing. Shares of Avantor Inc (US05352A1007) last closed on Nasdaq at 9.57 US dollars on 2026-06-18.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | US05352A1007 | AVTR | boerse | 69579250 | bgmi